First Saudi Translation Forum to Bring Together Specialists on Thursday to Discuss Issues Related to the Industry    SDRPY Opens Four Model Schools in Socotra    Saudi Stock Exchange Main Index Ends Trading Lower at 10,787 Points    Saudi Arabian Grand Prix Attracts World Attention to Jeddah Corniche Circuit    Dar AL-Hekma University Celebrates General Education    Residence, Exit, Re-entry and Visit Visas to Be Extended until 31/01/2022 Automatically Without Any Cost    Al-Eryani: Projects funded by KSrelief in Marib contributes to alleviating suffering of displaced    New batch of Saudi fuel derivatives grant arrives in Hadramout, Mahra    Riyadh Season to host @Hack as biggest cybersecurity event in region    UAE, China sign explanatory memorandum to boost customs, trade cooperation    Smarter digital power fundamental to meeting the Middle East's low-carbon ambitions, experts contend    stc pay ranked as one of the most popular digital only banks in the middle east    UK re-imposes face covering due to Omicron variant    Saudi Arabia Welcomes Australia's Intention to Designate Hezbollah, Its Political and Military Wings, as Terrorist Organization    Blinken commends S. Africa for quick detection of Omicron    24 new COVID-19 cases recorded in Kingdom    Archaeologists find 800-year-old mummy in Peru    Saudi Arabia bans flights to and from 7 African countries due to Omicron    Forum to discuss challenges of combating trafficking in persons    'Disability reminds us that there is no such thing as normal'    Bollywood superstar Salman Khan to dazzle Riyadh Season on Dec. 10    Palestinian President Receives Jordanian Foreign Minister    Riyadh Season to Host @Hack As Biggest Cybersecurity Event for 1st Time in Region    Ministry of Industry and Mineral Resources Wins "Business Change and Transformation" Award from ICXA    Board of Directors of King Abdulaziz Foundation for Islamic Studies and Human Sciences Convenes in Casablanca    Musical theater legend Sondheim dies aged 91    Indian embassy inaugurates international film festival    Sport minister to reveal details of Saudi Dakar Rally 2022    STC Group Wins 2021 Effie Middle East Gold Awards    Custodian of the Two Holy Mosques Condoles Russian President on Victims of an Accident inside a Coal Mine in Siberia    Brazil Records 12,392 New Cases of COVID-19    Dubai hosts the world's largest run with 146,000 participants    President, CEO of Saudi Arabian Fencing Federation to Participate in International Fencing Federation Congress    Russia says it opposes politicizing Beijing Winter Olympics    French footballer Karim Benzema found guilty in sex tape blackmail scandal    Al-Hilal Wins AFC Champions League 2021    United Through Sports World Virtual Youth Festival Kicks off Tomorrow in Turaif District    First Full International Marathon in Saudi Arabia to be Held in March 2022    Riyadh Art Launches Tuwaiq International Sculpture Symposium 2021    Winter Wonderland Circus Amazes Audience with Thrilling Acrobatic Shows    Royal Commission for AlUla Inaugurates AlUla Language Institute    Bollywood star's 'India got freedom in 2014' remark stirs controversy    23 Saudi women obtain favorable verdicts in 'adhl' lawsuits    Bride's fingerprint not required in revised e-marriage contract    Pilgrims Perform Dhuhr and Asr Prayers at Arafat Holy Site    Council of Senior Scholars: Muslim Brothers' Group Don't Represent Method of Islam, rather only Follows its Partisan Objectives, Violating our Graceful Religion    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Pfizer: COVID-19 vaccine 91% effective in children aged 5-11
Published in The Saudi Gazette on 23 - 10 - 2021

Pfizer/BioNTech announced Friday a study that showed smaller doses of its COVID-19 vaccine for children ages 5 to 11 appear safe and are nearly 91 percent effective at preventing symptomatic disease.
Pfizer's study was released ahead of a pivotal Food and Drug Administration (FDA) advisory panel meeting Oct. 26, where regulators will discuss whether to recommend authorizing the vaccine for younger kids.
The FDA will post its own analysis of Pfizer's safety and efficacy data later on Friday. If the panel votes favorably, and the agency accepts the recommendations, the Centers for Disease Control and Prevention will make the ultimate decision on who should get the shots.
FDA determines safety and efficacy, while CDC regulates the actual practice of medicine. If the vaccine is authorized, children could begin getting immunized in early November, with both doses completed in time for Christmas for the earliest ones in line.
The Biden administration has already purchased enough doses for the 28 million children who would be eligible if the vaccine is authorized.
The Pfizer vaccines has gone through several stages of testing before they can be made available to the public. Phase 1 tests safety and assesses if the vaccine induces a proper immune response by giving it to healthy volunteers.
In Phase 2, the vaccine is given to people with the characteristics similar to those for whom the vaccine is intended — in this case ages 5-11. Phase 3 involves giving the vaccine to thousands of people in the target group to test for safety and efficacy.
These phases of the trial included 2,268 children aged 5-11. Trial participants were given two doses of the vaccine, 21 days apart. Each dose was 10 micrograms, which is smaller than the 30-microgram doses given to people 12 and older.
This smaller dose was selected with careful thought to safety, tolerability and immunogenicity — or ability to cause an immune response — in children in this age group. The children's immune responses to these doses were comparable to the responses seen in people ages 12 and older with the larger doses. — Agencies

Clic here to read the story from its source.